| Metric | Value | Detail |
|---|---|---|
| Revenue | $58.9B | +7.7% YoY |
| Net income | $8.0B | 13.6% margin |
| Gross margin | n/a | Gross profit / revenue |
| Operating margin | n/a | Operating income / revenue |
| Return on equity | 12% | Net income / equity |
| Return on assets | 7% | Net income / assets |
| Revenue growth (YoY) | +7.7% | FY2024 to FY2025 |
| Revenue 3-yr CAGR | -9.1% | Compound annual |
| Diluted EPS | $6.36 | FY2025 |
| Debt-to-equity | n/a | Long-term debt / equity |
| Current ratio | 1.30 | Current assets / liabilities |
| Cash & equivalents | $6.9B | Balance sheet |
| Total assets | $121.9B | FY2025 year-end |
| Shareholders’ equity | $64.5B | FY2025 year-end |
| Share price | $109.04 | Delayed · 2026-07-10 |
| Market cap | $132.8B | Price × shares outstanding |
| P/E ratio | 16.6 | Market cap / net income |
| P/S ratio | 2.3 | Market cap / revenue |
| Dividend yield | 2.92% | Dividend / price |
Stock fundamentals · FY2025 · SEC 10-K data
CONOCOPHILLIPS (COP) stock fundamentals
CONOCOPHILLIPS (COP) reported $58.9B in revenue and $8.0B in net income in fiscal 2025, a 13.6% net margin, per its latest SEC 10-K filing. It carries a market capitalization of about $132.8B at a delayed share price. It scores 42/100 on WealthyBud's Investor Score, ranking #68 of 100 covered companies. Score is research, not investment advice.
Revenue (FY2025)
$58.9B
▲ +7.7% YoY
Net income
$8.0B
13.6% net margin
Market cap
$132.8B
Price $109.04 · delayed
P/E ratio
16.6
Price / earnings
Return on equity
12%
Net income / equity
Investor Score
42/100
#68 of 100 covered
CONOCOPHILLIPS fundamentals at a glance
The table summarizes CONOCOPHILLIPS's key financial figures for fiscal 2025 — revenue, profitability, returns, growth and balance-sheet strength — each taken from the company's SEC 10-K filing.
How profitable is CONOCOPHILLIPS?
CONOCOPHILLIPS runs a 13.6% net margin and n/a gross margin in fiscal 2025, turning $58.9B of revenue into $8.0B of profit. Return on equity is 12% and return on assets 7%.
Is CONOCOPHILLIPS growing?
CONOCOPHILLIPS's revenue changed +7.7% in fiscal 2025 and compounded at -9.1% a year over three years, reaching $58.9B. Diluted earnings per share were $6.36 for the year.
| Fiscal year | Revenue | Growth |
|---|---|---|
| 2021 | $45.8B | n/a |
| 2022 | $78.5B | +71.3% |
| 2023 | $56.1B | -28.5% |
| 2024 | $54.7B | -2.5% |
| 2025 | $58.9B | +7.7% |
How is CONOCOPHILLIPS valued?
CONOCOPHILLIPS carries a market capitalization of $132.8B at a delayed share price of $109.04, trading at a 16.6 price-to-earnings ratio and 2.3 price-to-sales with a 2.92% dividend yield. Its Value subscore is 79/100 across the covered universe.
How financially healthy is CONOCOPHILLIPS?
CONOCOPHILLIPS ended fiscal 2025 with $6.9B in cash, a debt-to-equity ratio of n/a and a current ratio of 1.30. Lower leverage and a current ratio above 1.0 signal a stronger balance sheet.
What is CONOCOPHILLIPS's Investor Score?
CONOCOPHILLIPS scores 42/100 on WealthyBud's Investor Score, #68 of 100 covered companies as of 2026-07-10. The score blends growth, profitability, returns on capital, balance-sheet strength and value into one percentile. It is a research opinion, not investment advice.
Investor Score
42/100
#68 of 100 covered companies
Subscores are percentile ranks (0–100) across the 100 covered companies, computed from the SEC fundamentals and delayed market price cited on this page. Data-derived opinion, not investment advice.
CONOCOPHILLIPS (COP) stock FAQ
How much revenue does CONOCOPHILLIPS make?
CONOCOPHILLIPS (COP) reported $58.9B in revenue in fiscal 2025, +7.7% versus the prior year, according to its SEC 10-K filing. Over the past three years its revenue has compounded at -9.1% a year.
Is CONOCOPHILLIPS profitable?
Yes. CONOCOPHILLIPS earned $8.0B in net income in fiscal 2025, a 13.6% net margin. Its return on equity was 12% and return on assets 7%, based on figures from its latest 10-K.
How fast is CONOCOPHILLIPS growing?
CONOCOPHILLIPS's revenue changed +7.7% year over year in fiscal 2025 and compounded at -9.1% annually over three years. Growth is one of four inputs to its WealthyBud Investor Score, scored 25/100 versus the covered universe.
What is CONOCOPHILLIPS's market cap and P/E ratio?
CONOCOPHILLIPS has a market capitalization of $132.8B at a delayed share price of $109.04, trading at a price-to-earnings ratio of 16.6 and price-to-sales of 2.3. Its dividend yield is 2.92%. Prices are delayed and illustrative.
What is CONOCOPHILLIPS's WealthyBud Investor Score?
CONOCOPHILLIPS scores 42/100, ranking #68 of 100 covered companies as of 2026-07-10. The score is a percentile blend of growth (25), profitability (39), returns on capital (29), balance-sheet strength (59) and value (79). It is a research opinion, not investment advice.
Where does this CONOCOPHILLIPS financial data come from?
Fundamentals come from CONOCOPHILLIPS's annual report (Form 10-K) filed with the SEC, via the public-domain EDGAR database. The share price used for market cap, P/E and yield is a delayed end-of-day quote, shown as illustrative; a production site would use a licensed real-time market-data feed.
Fundamentals are drawn from CONOCOPHILLIPS’s FY2025 Form 10-K filed with the
SEC (EDGAR, public domain), retrieved 2026-07-10. Share price is a delayed end-of-day quote; market cap, P/E, P/S
and dividend yield are illustrative and not real-time. The Investor Score is a data-derived research opinion.
Not investment advice.
Related
More large-cap stocks
Stocks
CVS HEALTH Corp (CVS)
$132.9B market cap · Investor Score 23/100
View StocksSalesforce, Inc. (CRM)
$133.8B market cap · Investor Score 56/100
View StocksPROGRESSIVE CORP/OH/ (PGR)
$134.8B market cap · Investor Score 67/100
View ResearchU.S. Stock Market Statistics (2026)
Market cap, valuation and concentration data across the U.S. stock market.
View